To further assess the effects of the PRGs in HCC, a five-PRG risk model, including GSDME, NOD1, PLCG1, NLRP6 and NLRC4, was identified to be greatly linked with the overall survival (OS) of HCC patients. Here, NLRC4 is linked to hepatocellular carcinoma.